Other content in this Stream
Release of medical records webinar — key takeaways and resources
A summary from the webinar “Release of medical records: Review of hot topics” presented on May 26, 2020.
It is imperative to have a system in place that allows the release of complete, legible, and organized records from your medical office.
Reporter 2009 General Surgery
Failure to diagnose complications; PIAA releases general surgery closed claim data; EMR product evaluation tool now available from TMA
The Reporter March-April 2007
EMR risk management; Breast implant surgery; FDA recalls; Dissolute documentation? TMB rewrites rules for medical records (expired CME); TMB process; Failure to timely evaluate; Delay in reporting
EHR best practices
Consider these guidelines to help reduce risk related to EHR systems
6 tips to improve patient communication while using your EHR
View part three of a three-part video series on improving physician/patient interactions.
The Reporter Volume 5 2015
TMLT's 2015 Texas legislative successes; Gaining the best value from your EHR (2.5-hour CME)
The Reporter Volume 2 2015
EHR best practices: complying with new TMB documentation rules: Advanced Practice Providers: Rules, Regulations, and Physician Supervision (CME activity); New telemedicine rules.
The Reporter November-December 2010
Electronic medical records and emerging changes to HIPAA; There is an "e" in medicine (CME); FDA restricts access to diabetes drug rosiglitazone (Avandia)
Reporter 2009 Pediatrics
Failure to diagnose meningitis; PIAA releases national pediatric closed claim data; EMR product evaluation tool now available from TMA
Potential pitfalls: Risk management for the EMR
Documentation pitfalls specifically related to electronic medical records (EMRs) and how to avoid them.
The Reporter July-August 2005
Drug name confusion; Electronic health records (exp. CME); Failure to communicate diagnosis of abdominal cancer; 2005 legislative update
The Reporter May-June 2002
The move to electronic medicine; Medical liability update; Failure/delay in diagnosis: Cancer; Botox parties, FDA prescription drug notices, changes in generic drug substitution laws